Alamar Biosciences

aid: alamar-biosciences
name: Alamar Biosciences
description: 'Alamar Biosciences is a privately held life sciences company headquartered in Fremont, California, building
  precision proteomics tools aimed at the earliest detection of disease. Its NULISA (NUcleic acid Linked Immuno-Sandwich Assay)
  chemistry and Attobody reagents, run on the ARGO and ARGO HT automated immunoassay systems, deliver attomolar-sensitivity,
  high-multiplex protein measurement for biomarker discovery, translational research, neurodegeneration and immuno-oncology
  panels. Alamar publishes no public web API. Its developer-facing surface is open source rather than service based: the first-party
  NULISAseqR R package (GPL-3) for importing, normalizing, quality-controlling and analyzing NULISAseq XML output, documented
  at nulisaseqr.alamarbio.com, alongside the NULISA Analysis Software (NAS) that ships with the instruments.'
url: https://raw.githubusercontent.com/api-evangelist/alamar-biosciences/refs/heads/main/apis.yml
image: https://avatars.githubusercontent.com/u/72825231?v=4
x-type: company
x-source: harvest:secondary-market
x-secondary-market: https://forgeglobal.com/alamar-biosciences_stock/
x-tier: profile
x-tier-reason: enrichment-pass
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Proteomics
- Life Sciences
- Biotechnology
- Biomarkers
- Diagnostics
- Bioinformatics
- Laboratory Instruments
- Open Source
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: IssueTracker
  url: https://github.com/Alamar-Biosciences/NULISAseqR/issues
- type: Releases
  url: https://github.com/Alamar-Biosciences/NULISAseqR/releases
- type: License
  name: GPL-3.0
  url: https://github.com/Alamar-Biosciences/NULISAseqR/blob/main/LICENSE
- type: Website
  url: https://alamarbio.com/
- type: GitHubOrganization
  url: https://github.com/Alamar-Biosciences
- type: GitHubRepository
  url: https://github.com/Alamar-Biosciences/NULISAseqR
- type: Documentation
  url: https://nulisaseqr.alamarbio.com/
- type: OpenSource
  url: https://github.com/Alamar-Biosciences/NULISAseqR
- type: Packages
  url: packages/alamar-biosciences-packages.yml
- type: ChangeLog
  url: changelog/alamar-biosciences-changelog.yml
- type: LLMsTxt
  url: llms/alamar-biosciences-llms.txt
- type: DomainSecurity
  url: security/alamar-biosciences-domain-security.yml
- type: Website
  url: https://alamarbio.com
- type: Blog
  url: https://alamarbio.com/blog/
- type: Support
  url: https://alamarbio.com/contact-us/
- type: PrivacyPolicy
  url: https://alamarbio.com/privacy-policy/
- type: LLMsTxt
  url: llms/alamar-biosciences-llms.txt
- type: DomainSecurity
  url: security/alamar-biosciences-domain-security.yml
- type: LLMsTxt
  url: llms/alamar-biosciences-llms.txt
- type: DomainSecurity
  url: security/alamar-biosciences-domain-security.yml
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 5
  pass: local-v1
x-coverage:
  state: blocked
  reason: bot-challenge
  detail: Every path on alamarbio.com — including /robots.txt and a deliberately bogus control path — answers HTTP 202 with
    a Sucuri sgcaptcha interstitial instead of the page, so not one page of Alamar's own site could be read; the only readable
    first-party surface was the GitHub org and the NULISAseqR pkgdown docs, and no api/developer/docs subdomain exists to
    probe.
  evidence:
  - url: https://alamarbio.com/robots.txt
    status: 202
  - url: https://alamarbio.com/.well-known/agent-card.json
    status: 202
  - url: https://nulisaseqr.alamarbio.com/
    status: 200
  - url: https://api.github.com/orgs/Alamar-Biosciences/repos
    status: 200
  checked: '2026-08-06'